WallStreetZenWallStreetZen

NASDAQ: DCGO
Docgo Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DCGO

Based on 1 analyst offering 12 month price targets for Docgo Inc

Min Forecast
$1.50+95.57%
Avg Forecast
$1.50+95.57%
Max Forecast
$1.50+95.57%

Should I buy or sell DCGO stock?

Based on 1 analyst offering ratings for Docgo Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although DCGO's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates DCGO as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their DCGO stock forecasts and price targets.

DCGO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-12

1 of 1

Forecast return on equity

Is DCGO forecast to generate an efficient return?

Company
-8.24%
Industry
-57.23%
Market
356.86%
DCGO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DCGO forecast to generate an efficient return on assets?

Company
-6.3%
Industry
9.95%
DCGO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DCGO earnings per share forecast

What is DCGO's earnings per share in the next 2 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.35
Avg 2 year Forecast
-$0.23

DCGO revenue forecast

What is DCGO's revenue in the next 2 years based on estimates from 8 analysts?

Avg 1 year Forecast
$297.2M-19.27%
Avg 2 year Forecast
$324.0M-11.98%
DCGO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DCGO revenue growth forecast

How is DCGO forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
-19.27%
Industry
9.92%
Market
1,548.38%
DCGO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DCGO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DCGO vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
DCGO$0.77$1.50+95.57%Hold
BTMD$2.09$4.00+91.39%Hold
CCEL$3.32N/AN/A
CCM$4.06N/AN/A
AMS$2.12N/AN/A
View Top Medical Care Facility Stocks

Docgo Stock Forecast FAQ

Is Docgo Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DCGO) stock is to Hold DCGO stock.

Out of 1 analyst, 0 (0%) are recommending DCGO as a Strong Buy, 0 (0%) are recommending DCGO as a Buy, 1 (100%) are recommending DCGO as a Hold, 0 (0%) are recommending DCGO as a Sell, and 0 (0%) are recommending DCGO as a Strong Sell.

If you're new to stock investing, here's how to buy Docgo stock.

What is DCGO's earnings growth forecast for 2026-2027?

(NASDAQ: DCGO) Docgo's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 31.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,205.54%.

Docgo's earnings in 2026 is -$51,591,757.On average, 8 Wall Street analysts forecast DCGO's earnings for 2026 to be -$34,322,712, with the lowest DCGO earnings forecast at -$50,804,265, and the highest DCGO earnings forecast at -$15,405,606.

In 2027, DCGO is forecast to generate -$22,281,886 in earnings, with the lowest earnings forecast at -$27,798,560 and the highest earnings forecast at -$18,486,727.

What is DCGO's revenue growth forecast for 2026-2027?

(NASDAQ: DCGO) Docgo's forecast annual revenue growth rate of -19.27% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 9.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,548.38%.

Docgo's revenue in 2026 is $368,093,385.On average, 8 Wall Street analysts forecast DCGO's revenue for 2026 to be $29,068,177,891, with the lowest DCGO revenue forecast at $27,683,140,543, and the highest DCGO revenue forecast at $30,482,559,250.

In 2027, DCGO is forecast to generate $31,690,554,394 in revenue, with the lowest revenue forecast at $29,476,059,652 and the highest revenue forecast at $33,471,735,898.

What is DCGO's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: DCGO) forecast ROA is -6.3%, which is lower than the forecast US Medical Care Facilities industry average of 9.95%.

What is DCGO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DCGO price target, the average DCGO price target is $1.50, with the highest DCGO stock price forecast at $1.50 and the lowest DCGO stock price forecast at $1.50.

The Wall Street analyst predicted that Docgo's share price could reach $1.50 by Nov 12, 2026. The average Docgo stock price prediction forecasts a potential upside of 95.57% from the current DCGO share price of $0.77.

What is DCGO's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: DCGO) Docgo's current Earnings Per Share (EPS) is -$0.51. On average, analysts forecast that DCGO's EPS will be -$0.35 for 2026, with the lowest EPS forecast at -$0.52, and the highest EPS forecast at -$0.16. In 2027, DCGO's EPS is forecast to hit -$0.23 (min: -$0.28, max: -$0.19).

What is DCGO's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: DCGO) forecast ROE is -8.24%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.